In patients with polycystic ovarian syndrome (PCOS), a retrospective cohort study compared metformin and GLP‐1 RA treatment and found that GLP‐1 RA was associated with a lower risk of incident breast cancer compared to patients taking metformin. This evidence concerns the gene GCG and breast carcinoma.